Covid-19 and Merger Arbitrage Trading
Covid-19 and Merger Arbitrage Trading
Covid-19 and merger arbitrage trading has a relationship extending far beyond the immediate profitability of this event driven strategy. As many of the event driven…
Merger Arbitrage Spread Performance
Merger Arbitrage Spread Performance – 9 February 2020
This is the weekly analysis of Merger Arbitrage Spread Performance February 9, 2020. This reports covers the top 20 investable US cash based merger arbitrage…
Merger Arbitrage Spread Performance – 27 October 2019
This is the weekly analysis of Merger Arbitrage Spread Performance October 27, 2019. This reports covers the top 20 investable US cash based merger arbitrage…
Merger Arbitrage Spread Performance – 20 October 2019
This is the weekly analysis of Merger Arbitrage Spread Performance October 20, 2019. This reports covers the top 20 investable US cash based merger arbitrage…
Ra Pharmaceuticals (NASDAQ: RARX) Takeover
Ra Pharmaceuticals (RARX) Merger – Acquisition Details
UCB and Ra Pharmaceuticals (RARX) merger information such as expected completion date and offer price are displayed in the deal information table below. This factsheet is an invaluable data source for traders & investors looking to familiarize themselves with the UCB takeover of Ra Pharmaceuticals (RARX) and trade the merger arbitrage spread.
